Gang Xu

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures

Yingjie Ding, Yuesheng Zuo, Bin Zhang et al. · Cell · 2025 · 106 citations

Life Sciences, Bioinformatics, Molecular Biology +14

Senescence-resistant human mesenchymal progenitor cells counter aging in primates

Jinghui Lei, Zijuan Xin, Ning Liu et al. · Cell · 2025 · 53 citations

Education, Cell Biology, Genetics +12

Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis

Qiang Guo, Xixian Ke, Zhou Liu et al. · Frontiers in Genetics · 2020 · 42 citations · Full text

Medicine, Molecular Biology, Oncology +17

CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling

Gang Xu, Chengxue Dang · Cancer Cell International · 2017 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +17